| Kevin Dwain Marler, MD | |
|
440 Prime Pt, Peachtree City, GA 30269-3309 | |
| (770) 487-1454 | |
| Not Available |
| Full Name | Kevin Dwain Marler |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 440 Prime Pt, Peachtree City, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932395415 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 55782 (Georgia) | Primary |
| 208D00000X | General Practice | A51203 (California) | Secondary |
| 208D00000X | General Practice | 28318 (Kentucky) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Kevin Dwain Marler, MD 440 Prime Pt, Peachtree City, GA 30269-3309 Ph: (770) 487-1454 | Kevin Dwain Marler, MD 440 Prime Pt, Peachtree City, GA 30269-3309 Ph: (770) 487-1454 |
News Archive
Telesta Therapeutics Inc. announced today that it has submitted electronically, through its U.S. agent, a Biologics License Application (BLA) to the United States Food and Drug Administration for MCNA. MCNA is Telesta's novel biologic immunotherapeutic for the treatment of high-risk non-muscle invasive bladder cancer patients who have failed first-line BCG therapy.
Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, and the University of Birmingham have signed a licensing agreement to commercialise a novel anti-viral nasal spray that protects against COVID-19.
Mustafa al'Absi, Ph.D., professor of behavioral sciences at the University of Minnesota Medical School - Duluth Campus, and director of the Duluth Medical Research Institute, has received funding and launched a new first-of-its-kind international research initiative: "Khat Research Program: Neurobehavioral Impact of Long-Term Use".
Many companies in the cell therapy regenerative medicine market including Roche, Genzyme, Athersys, Miltenyi Biotec, Hospira, Lonza and Life Technologies will join ISCT to launch a series of new initiatives that will create greater strategic alignment within the industry and drive late stage clinical development.
› Verified 8 days ago
Dr. Christopher Alton Edens, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 2011 Commerce Dr N Ste 25, Peachtree City, GA 30269 Phone: 478-542-0311 |